Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
  • About Us
    • Editorial Profile
    • Editorial Calendar
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
 
 
 
 
  • Could Using CRISPR To Edit Embryos Save People Who Are Already Alive?

    STAT | The technology is not advanced enough yet, but the idea of editing DNA to produce a savior sibling may be theoretically possible.

    Sep 16, 2019
  • Space Is The New Frontier For Life Sciences Research

    Bio-IT World | Advances in microfluidics, the shift from animal-based to cell-based models of drug research, and the ability to grow larger and more perfect protein crystals in microgravity have all helped propel space-based research into a thriving commercial enterprise.

    Sep 16, 2019
  • Glowing Cholesterol A Game-Changer For Study Of Heart Disease

    Bio-IT World | A new technique that lights up a protein shuttling LDL cholesterol around the circulatory system has made it financially feasible to do high-throughput screening for cardiovascular drugs as well as measure the size of LDL particles—an important but poorly-understood disease risk factor.

    Sep 13, 2019
  • Why Aren’t There Better Cancer Drugs? Scientists May Have Picked the Wrong Targets

    The New York Times | Drugs can stop cancer cells if they attack the right proteins. But many of these targets were chosen with dated, imprecise technology, a new study suggests.

    Sep 12, 2019
  • «
  • 261
  • 262
  • 263
  • 264
  • 265
  • 266
  • 267
  • 268 (current)
  • 269
  • 270
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: [email protected]

Twitter Icon LinkedIn Icon Facebook Icon

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy